1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Vermont Caring for Children Foundation Grant Application is a grant from the Vermont Caring for Children Foundation, a philanthropic initiative of Blue Cross Blue Shield of Vermont, that funds community programs serving children and families across Vermont. Eligible applicants are local nonprofit organizations based in Vermont.
The application requires a project narrative addressing purpose, target population, budget, other funding sources, and partner organizations. Applicants must also disclose any conflicts of interest with Blue Cross and Blue Shield of Vermont and certify compliance with grantee commitments. Grant amount is unspecified and determined on a per-application basis.
Organizations may be asked to submit annual reports or fiscal sponsorship documentation.
Get alerted about grants like this
Save a search for “Vermont Caring for Children Foundation (Blue Cross Blue Shield of Vermont)” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Name of Organization: ______________________________________________________________________________ Contact Person(s): __________________________________________________________________________________ Organizational Headquarters: _____________________________________________________________________ _____________________________________________________________________ _____________________________________________________________________ Phone Number: ____________________________ Email: ________________________________________________ In addition to this application, include a narrative description of your project.
Please answer the following questions: 1. What is the specific purpose of this grant request? 2.
What is the target population that will be served or impacted by grant? 3. What is the total project or organizational budget?
4. What is the specific grant request amount? 5.
What are the other funding sources? 6. What other organizations are or will be involved in the work?
If available please provide an annual report of the program and/or documentation of a fiscal agent or sponsor. PLEASE READ, COMPLETE AND SIGN: Conflict of Interest and grantee commitment statements • Does the requesting organization, governing board or individual have any relationship with Blue Cross and Blue Shield of Vermont?
Yes No If yes, please explain: _________________________________________________________________________ • Does the requesting governing board or individual receive compensation of any kind for their work with the applying organization?
Yes No If yes please explain: _________________________________________________________________________ This grant is conditional upon your commitment that: • The award will be publicized as appropriate with our prior approval. • A brief report will be submitted no later than one month after completion of the program, describing the impacts of the program.
• The awarded funds shall be used exclusively for the purposes and projects set forth in the application. • If the Grantee dissolves or becomes inactive, or the funded project lapses or is discontinued, the Grantee will notify Blue Cross and Blue Shield of Vermont. Signature: _________________________________________________________ Date: _______________________ revised 08/2018 # Vermont Caring for Children Foundation
Based on current listing details, eligibility includes: Local nonprofit community organizations in Vermont. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates Unspecified Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is rolling deadlines or periodic funding windows. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.
-Purpose. This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop, standardize, and validate new and innovative assays, integrated strategies, or batteries of assays that determine or predict specific organ toxicities (e.g., ocular, dermal, hematotoxicity, cardiotoxicity, gastrointestinal toxicity, hepatotoxicity, nephrotoxicity, ototoxicity, olfactory loss, bladder toxicity, neurotoxicity, pulmonary toxicity, endocrine toxicity, and pancreatic beta cell toxicity), resulting from both acute and chronic exposures to various chemicals, environmental pollutants, biologics and therapeutic molecules or drugs. In addition, this FOA encourages the development, standardization, and validation of new models of arthritis, convulsion, infection and shock. New approaches for high throughput toxicity screening that involves the use of molecular endpoints, computer modeling, proteomics, genomics and epigenomics and the development of virtual tissues are also encouraged as are development of 3-dimensional organ models for toxicity evaluation. -Mechanism of Support. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with a FOA of identical scientific scope, PA-09-007, which encourages applications under the Small Business Technology Transfer (STTR) (R41/R42) grant mechanisms. Funding Opportunity Number: PA-09-006. Assistance Listing: 93.113,93.173,93.361,93.389,93.837,93.846,93.847,93.848,93.849,93.859,93.867. Funding Instrument: G. Category: ED,ENV,FN,HL.
Purpose. This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), invites Small Business Innovation Research (SBIR) cooperative agreement applications from small business concerns (SBCs) that propose to develop new, or to improve existing application(s) of nanotechnology-based therapeutics or/and in vivo diagnostics. This FOA will specifically support pre-clinical optimization and testing of these cancer-relevant nanotechnology applications against the intended cancer type. The proposed projects must be milestone-driven and must be clearly directed toward development of an ultimate commercial product. The outcomes are expected to advance the discovery and pre-clinical optimization phase so that an Investigational New Drug (IND) or Investigational Device Exemptions (IDE) application could be submitted to the Food and Drug Administration (FDA) by the end or shortly after completion of the Phase II project period. To facilitate these steps, the NCI will assist the awardees in various ways, including the support through the NCI-sponsored Nanotechnology Characterization Laboratory. This FOA will NOT support basic research projects, studies on disease mechanisms, and clinical trials. Mechanism of Support. This FOA will utilize the SBIR (U43/U44) cooperative agreement mechanisms for Phase I and Phase II applications. Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. Funding Opportunity Number: PAR-10-286. Assistance Listing: 93.393,93.394,93.395,93.396. Funding Instrument: CA. Category: ED,HL. Award Amount: Up to $150K per award.
This Funding Opportunity Announcement (FOA) invites Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) for funding to perform research leading to the development of innovative technologies that may advance progress for early detection and assessment of individuals at risk and for early diagnosis, prognosis and follow-up of type 1 diabetes (T1D). Funding Opportunity Number: RFA-DK-15-024. Assistance Listing: 93.847. Funding Instrument: G. Category: FN,HL. Award Amount: $2M total program funding.